BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33074188)

  • 1. Andersen-Tawil Syndrome Presenting with Complete Heart Block.
    Suetterlin K; Männikkö R; Flossmann E; Sud R; Fialho D; Vivekanandam V; James N; Gossios TD; Hanna MG; Savvatis K; Matthews E
    J Neuromuscul Dis; 2021; 8(1):151-154. PubMed ID: 33074188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrafamilial phenotypic variability in Andersen-Tawil syndrome: A diagnostic challenge in a potentially treatable condition.
    Ardissone A; Sansone V; Colleoni L; Bernasconi P; Moroni I
    Neuromuscul Disord; 2017 Mar; 27(3):294-297. PubMed ID: 28024840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden cardiac death in Andersen-Tawil syndrome.
    Peters S; Schulze-Bahr E; Etheridge SP; Tristani-Firouzi M
    Europace; 2007 Mar; 9(3):162-6. PubMed ID: 17272325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypokalemic periodic paralysis, facial dysmorphism and ventricular arrhythmia (clinical triad of Andersen-Tawil syndrome).
    Thakkar M; Biswas TK; Desle HB
    J Assoc Physicians India; 2012 Nov; 60():56-8. PubMed ID: 23767205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrocardiogram in Andersen-Tawil syndrome. New electrocardiographic criteria for diagnosis of type-1 Andersen-Tawil syndrome.
    Kukla P; Biernacka EK; Baranchuk A; Jastrzebski M; Jagodzinska M
    Curr Cardiol Rev; 2014 Aug; 10(3):222-8. PubMed ID: 24827800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypical variability and atypical presentations in a French cohort of Andersen-Tawil syndrome.
    Villar-Quiles RN; Sternberg D; Tredez G; Beatriz Romero N; Evangelista T; Lafôret P; Cintas P; Sole G; Sacconi S; Bendahhou S; Franques J; Cances C; Noury JB; Delmont E; Blondy P; Perrin L; Hezode M; Fournier E; Fontaine B; Stojkovic T; Vicart S
    Eur J Neurol; 2022 Aug; 29(8):2398-2411. PubMed ID: 35460302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations.
    Miyamoto K; Aiba T; Kimura H; Hayashi H; Ohno S; Yasuoka C; Tanioka Y; Tsuchiya T; Yoshida Y; Hayashi H; Tsuboi I; Nakajima I; Ishibashi K; Okamura H; Noda T; Ishihara M; Anzai T; Yasuda S; Miyamoto Y; Kamakura S; Kusano K; Ogawa H; Horie M; Shimizu W
    Heart Rhythm; 2015 Mar; 12(3):596-603. PubMed ID: 25496985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome.
    Fernlund E; Lundin C; Hertervig E; Kongstad O; Alders M; Platonov P
    Ann Noninvasive Electrocardiol; 2013 Sep; 18(5):471-8. PubMed ID: 24047492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Andersen-Tawil syndrome: report of 3 novel mutations and high risk of symptomatic cardiac involvement.
    Kostera-Pruszczyk A; Potulska-Chromik A; Pruszczyk P; Bieganowska K; Miszczak-Knecht M; Bienias P; Szczałuba K; Lee HY; Quinn E; Ploski R; Kaminska A; Ptáček LJ
    Muscle Nerve; 2015 Feb; 51(2):192-6. PubMed ID: 24861851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic management of ventricular arrhythmias in Andersen-Tawil syndrome.
    Maffè S; Paffoni P; Bergamasco L; Dellavesa P; Zenone F; Baduena L; Franchetti Pardo N; Careri G; Facchini E; Sansone V; Parravicini U
    J Electrocardiol; 2020; 58():37-42. PubMed ID: 31710873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular tachyarrhythmias in a patient with Andersen-Tawil syndrome.
    Pyo JY; Joh DH; Park JS; Lee SJ; Lee H; Kim W; Joung B
    Korean Circ J; 2013 Jan; 43(1):62-5. PubMed ID: 23407770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Andersen-Tawil syndrome with early fixed myopathy.
    Lefter S; Hardiman O; Costigan D; Lynch B; McConville J; Hand CK; Ryan AM
    J Clin Neuromuscul Dis; 2014 Dec; 16(2):79-82. PubMed ID: 25415519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Andersen-Tawil syndrome: deep phenotyping reveals significant cardiac and neuromuscular morbidity.
    Vivekanandam V; Männikkö R; Skorupinska I; Germain L; Gray B; Wedderburn S; Kozyra D; Sud R; James N; Holmes S; Savvatis K; Fialho D; Merve A; Pattni J; Farrugia M; Behr ER; Marini-Bettolo C; Hanna MG; Matthews E
    Brain; 2022 Jun; 145(6):2108-2120. PubMed ID: 34919635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Andersen-Tawil syndrome: clinical and molecular aspects.
    Nguyen HL; Pieper GH; Wilders R
    Int J Cardiol; 2013 Dec; 170(1):1-16. PubMed ID: 24383070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Andersen-Tawil syndrome. Efficacy of class IC drugs].
    Makarov LM; Komoliatova VN; Kolosov VO; Fedina NN; Solokhin IuA
    Kardiologiia; 2013; 53(1):91-6. PubMed ID: 23548357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular stratification of arrhythmogenic mechanisms in the Andersen Tawil syndrome.
    Moreno-Manuel AI; Gutiérrez LK; Vera-Pedrosa ML; Cruz FM; Bermúdez-Jiménez FJ; Martínez-Carrascoso I; Sánchez-Pérez P; Macías Á; Jalife J
    Cardiovasc Res; 2023 May; 119(4):919-932. PubMed ID: 35892314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kir 2.1 channelopathies: the Andersen-Tawil syndrome.
    Tristani-Firouzi M; Etheridge SP
    Pflugers Arch; 2010 Jul; 460(2):289-94. PubMed ID: 20306271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and neurophysiological variability in Andersen-Tawil syndrome.
    Kokubun N; Aoki R; Nagashima T; Komagamine T; Kuroda Y; Horie M; Hirata K
    Muscle Nerve; 2019 Dec; 60(6):752-757. PubMed ID: 31509255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome.
    Haruna Y; Kobori A; Makiyama T; Yoshida H; Akao M; Doi T; Tsuji K; Ono S; Nishio Y; Shimizu W; Inoue T; Murakami T; Tsuboi N; Yamanouchi H; Ushinohama H; Nakamura Y; Yoshinaga M; Horigome H; Aizawa Y; Kita T; Horie M
    Hum Mutat; 2007 Feb; 28(2):208. PubMed ID: 17221872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry.
    Barajas-Martinez H; Hu D; Ontiveros G; Caceres G; Desai M; Burashnikov E; Scaglione J; Antzelevitch C
    Circ Cardiovasc Genet; 2011 Feb; 4(1):51-7. PubMed ID: 21148745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.